• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

USP1 去泛素化酶通过限制其依赖于 DDB1 的降解来维持磷酸化的 CHK1。

USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation.

机构信息

Genome Instability and Carcinogenesis UPR3081 CNRS, IGC, IMM, 31 chemin Joseph Aiguier, 13402 Marseille, France.

出版信息

Hum Mol Genet. 2011 Jun 1;20(11):2171-81. doi: 10.1093/hmg/ddr103. Epub 2011 Mar 9.

DOI:10.1093/hmg/ddr103
PMID:21389083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3090195/
Abstract

The maintenance of genetic stability depends on the fine-tuned initiation and termination of pathways involved in cell cycle checkpoints and DNA repair. Here, we describe a new pathway that regulates checkpoint kinase 1 (CHK1) activity, a key element controlling both checkpoints and DNA repair. We show that the ubiquitin-specific peptidase 1 (USP1) deubiquitinase participates in the maintenance of both total and phosphorylated levels of CHK1 in response to genotoxic stress. We establish that USP1 depletion stimulates the damage-specific DNA-binding protein 1-dependent degradation of phosphorylated CHK1 in both a monoubiquitinylated Fanconi anaemia, complementation group D2 (FANCD2)-dependent and -independent manner. Our data support the existence of a circuit in which CHK1 activates checkpoints, DNA repair and proliferating cell nuclear antigen and FANCD2 monoubiquitinylation. The latter two events, in turn, switch off activated CHK1 by negative feedback inhibition, which contributes to the downregulation of the DNA damage response. This pathway, which is compromised in the cancer-prone disease Fanconi anaemia (FA), likely contributes to the hypersensitivity of cells from FA patients to DNA damage and to the clinical phenotype of the syndrome; it may also represent a pharmacological target to improve patient care and develop new cancer therapies.

摘要

遗传稳定性的维持依赖于细胞周期检查点和 DNA 修复途径的精细启动和终止。在这里,我们描述了一条新的通路,该通路调节检查点激酶 1(CHK1)的活性,这是控制检查点和 DNA 修复的关键因素。我们表明,泛素特异性肽酶 1(USP1)去泛素酶参与应对遗传毒性应激时总 CHK1 和磷酸化 CHK1 水平的维持。我们确定 USP1 耗竭以依赖和不依赖单泛素化范可尼贫血互补组 D2(FANCD2)的方式刺激损伤特异性 DNA 结合蛋白 1 依赖性磷酸化 CHK1 的降解。我们的数据支持这样一个回路的存在,即 CHK1 激活检查点、DNA 修复和增殖细胞核抗原以及 FANCD2 单泛素化。后两个事件反过来通过负反馈抑制关闭激活的 CHK1,这有助于下调 DNA 损伤反应。这条通路在易患癌症的范可尼贫血症(FA)中受到损害,可能导致 FA 患者的细胞对 DNA 损伤的敏感性增加,并导致该综合征的临床表型;它也可能代表一种药理学靶点,以改善患者护理并开发新的癌症疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/6c9b59fceaa2/ddr10305.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/704238dbc1c4/ddr10301.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/46ee2bc49f17/ddr10302.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/b525ada18940/ddr10303.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/8db1c53a8f88/ddr10304.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/6c9b59fceaa2/ddr10305.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/704238dbc1c4/ddr10301.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/46ee2bc49f17/ddr10302.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/b525ada18940/ddr10303.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/8db1c53a8f88/ddr10304.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a69d/3090195/6c9b59fceaa2/ddr10305.jpg

相似文献

1
USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation.USP1 去泛素化酶通过限制其依赖于 DDB1 的降解来维持磷酸化的 CHK1。
Hum Mol Genet. 2011 Jun 1;20(11):2171-81. doi: 10.1093/hmg/ddr103. Epub 2011 Mar 9.
2
Deubiquitination of FANCD2 is required for DNA crosslink repair.FANCD2的去泛素化是DNA交联修复所必需的。
Mol Cell. 2007 Dec 14;28(5):798-809. doi: 10.1016/j.molcel.2007.09.020.
3
Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.CHK1功能丧失会阻碍DNA损伤诱导的FANCD2单泛素化,但能使范可尼贫血中异常的G2期阻滞恢复正常。
Hum Mol Genet. 2008 Mar 1;17(5):679-89. doi: 10.1093/hmg/ddm340. Epub 2007 Nov 20.
4
Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.范可尼贫血/BRCA通路需要Chk1介导的FANCE磷酸化。
Mol Cell Biol. 2007 Apr;27(8):3098-108. doi: 10.1128/MCB.02357-06. Epub 2007 Feb 12.
5
A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway.一种含UAF1的多亚基蛋白复合物调节范可尼贫血途径。
Mol Cell. 2007 Dec 14;28(5):786-97. doi: 10.1016/j.molcel.2007.09.031.
6
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.去泛素化酶USP1调节范可尼贫血通路。
Mol Cell. 2005 Feb 4;17(3):331-9. doi: 10.1016/j.molcel.2005.01.008.
7
Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1.人类 ELG1 通过与 PCNA 和 USP1 的相互作用来调节泛素化增殖细胞核抗原 (PCNA) 的水平。
J Biol Chem. 2010 Apr 2;285(14):10362-9. doi: 10.1074/jbc.M109.092544. Epub 2010 Feb 9.
8
Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression.早幼粒细胞白血病蛋白调节范可尼贫血基因表达。
Int J Mol Sci. 2021 Jul 21;22(15):7782. doi: 10.3390/ijms22157782.
9
Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.小鼠Usp1的失活会导致基因组不稳定和范可尼贫血表型。
Dev Cell. 2009 Feb;16(2):314-20. doi: 10.1016/j.devcel.2009.01.001.
10
DNA requirement in FANCD2 deubiquitination by USP1-UAF1-RAD51AP1 in the Fanconi anemia DNA damage response.在范可尼贫血症 DNA 损伤反应中,USP1-UAF1-RAD51AP1 对 FANCD2 的去泛素化作用需要 DNA。
Nat Commun. 2019 Jun 28;10(1):2849. doi: 10.1038/s41467-019-10408-5.

引用本文的文献

1
Molecular regulation by ubiquitin-specific proteases (USPs) in HCC: cell cycle, oncogenic signaling, and beyond.泛素特异性蛋白酶(USP)在肝癌中的分子调控:细胞周期、致癌信号传导及其他方面。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 23. doi: 10.1007/s00210-025-04395-2.
2
PI5P4K inhibitors: promising opportunities and challenges.磷脂酰肌醇5-磷酸4-激酶抑制剂:充满希望的机遇与挑战
FEBS J. 2025 Jan 19. doi: 10.1111/febs.17393.
3
Deubiquitinases as novel therapeutic targets for diseases.去泛素化酶作为疾病的新型治疗靶点。

本文引用的文献

1
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.SLX4,一种结构特异性内切酶的协调蛋白,在一种新的范可尼贫血亚型中发生突变。
Nat Genet. 2011 Feb;43(2):138-41. doi: 10.1038/ng.751. Epub 2011 Jan 16.
2
Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia.Slx4 是结构特异性核酸酶的调节因子,其在小鼠中的缺失可导致范可尼贫血样表型。
Nat Genet. 2011 Feb;43(2):147-52. doi: 10.1038/ng.752. Epub 2011 Jan 16.
3
Mutations of the SLX4 gene in Fanconi anemia.SLX4 基因突变与范可尼贫血症。
MedComm (2020). 2024 Dec 13;5(12):e70036. doi: 10.1002/mco2.70036. eCollection 2024 Dec.
4
ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3.ATXN3:一种多功能蛋白,参与多聚谷氨酰胺疾病脊髓小脑共济失调 3 型。
Expert Rev Mol Med. 2024 Sep 25;26:e19. doi: 10.1017/erm.2024.10.
5
Deubiquitylating Enzymes in Cancer and Immunity.癌症与免疫中的去泛素化酶
Adv Sci (Weinh). 2023 Dec;10(36):e2303807. doi: 10.1002/advs.202303807. Epub 2023 Oct 27.
6
BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1.BRD7通过抑制USP1介导的CHK1去泛素化来抑制肿瘤对CHK1抑制剂的化疗敏感性。
Cell Death Discov. 2023 Aug 25;9(1):313. doi: 10.1038/s41420-023-01611-x.
7
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy.泛素特异性蛋白酶1:评估其在癌症治疗中的作用。
Clin Exp Med. 2023 Nov;23(7):2953-2966. doi: 10.1007/s10238-023-01075-4. Epub 2023 Apr 24.
8
Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells.PI3K/AKT 和 RHO/RAC/PAK 信号通路在 CHK1 抑制剂耐药的 Eµ-Myc 淋巴瘤细胞中的上调。
Biochem J. 2022 Oct 14;479(19):2131-2151. doi: 10.1042/BCJ20220103.
9
Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway.c-Rel 和 USP1 依赖性通路调控 CHK1 抑制剂耐药性。
Biochem J. 2022 Oct 14;479(19):2063-2086. doi: 10.1042/BCJ20220102.
10
Diet high in branched-chain amino acid promotes PDAC development by USP1-mediated BCAT2 stabilization.富含支链氨基酸的饮食通过USP1介导的BCAT2稳定促进胰腺癌发展。
Natl Sci Rev. 2021 Nov 26;9(5):nwab212. doi: 10.1093/nsr/nwab212. eCollection 2022 May.
Nat Genet. 2011 Feb;43(2):142-6. doi: 10.1038/ng.750. Epub 2011 Jan 16.
4
Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.自发终止 G₂DNA 损伤检查点具有临床益处,但会促进范可尼贫血患者的白血病发生。
J Clin Invest. 2011 Jan;121(1):184-94. doi: 10.1172/JCI43836. Epub 2010 Dec 22.
5
The DNA damage response: making it safe to play with knives.DNA 损伤反应:让“玩刀”变得安全。
Mol Cell. 2010 Oct 22;40(2):179-204. doi: 10.1016/j.molcel.2010.09.019.
6
Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.抑癌蛋白 PALB2 增强 RAD51 重组酶活性。
Nat Struct Mol Biol. 2010 Oct;17(10):1255-9. doi: 10.1038/nsmb.1916. Epub 2010 Sep 26.
7
Expanded roles of the Fanconi anemia pathway in preserving genomic stability.范可尼贫血途径在维持基因组稳定性中的扩展作用。
Genes Dev. 2010 Aug 15;24(16):1680-94. doi: 10.1101/gad.1955310.
8
Rad18-mediated translesion synthesis of bulky DNA adducts is coupled to activation of the Fanconi anemia DNA repair pathway.Rad18 介导的大体积 DNA 加合物的跨损伤合成与范可尼贫血症 DNA 修复途径的激活相关联。
J Biol Chem. 2010 Oct 8;285(41):31525-36. doi: 10.1074/jbc.M110.138206. Epub 2010 Jul 30.
9
DNA repair has a new FAN1 club.DNA 修复有了新的 FAN1 俱乐部。
Mol Cell. 2010 Jul 30;39(2):167-9. doi: 10.1016/j.molcel.2010.07.010.
10
Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia.抑制非同源末端连接可抑制范可尼贫血的 DNA 修复缺陷。
Mol Cell. 2010 Jul 9;39(1):25-35. doi: 10.1016/j.molcel.2010.06.026.